Our business

Unimedic Pharma supply the Nordic region and northern Europe with a wide range of licensed and unlicensed pharmaceuticals in several therapeutic areas. Our business is divided into three main areas: specialty pharmaceuticals (licensed), unlicensed pharmaceuticals and contract development and manufacturing organisation (CDMO).

An important part of our daily work is to continuously add new pharmaceutical to our product portfolio through drug development, acquisitions, and long-term strategic partnerships. Offering a wide range of pharmaceuticals strengthens our ambition to contribute to better health. The company’s head office is located in Solna, Sweden. We operate primarily in the Nordic region and northern Europe. Unimedic Pharma is a wholly owned subsidiary of MedCap AB (publ), listed on Nasdaq Stockholm Mid Cap.

Business area

Specialty pharmaceuticals

Unimedic Pharma supply the market with a wide range of licenced specialist pharmaceuticals within several therapeutic areas such as emergency care, pain management, infectious diseases, gastroenterology, urology and substance abuse.

In close collaboration with the healthcare sector, Unimedic Pharma develops pharmaceuticals for children and adults with special medical needs, pharmaceuticals which are supplied to the market as compounded drugs or licensed pharmaceuticals. We have a long tradition and experience in drug development, as well as in selecting optimal regulatory route for quick registration of pharmaceuticals and medical devices.

Unimedic Pharma drug development is based on proven compounds which reduce the time to market, and development costs compared with conventional drug development. Adding new pharmaceuticals to the company product portfolio through acquisitions and long-term strategic partnerships is an important part of our work. Our in-depth knowledge and experience of the pharmaceutical markets in the Nordic region, in combination with a solid company infrastructure, has established a successful track record of representing other pharma companies’ as MAH or local representative. Today, Unimedic Pharma is designated representative for a broad portfolio in emergency care, infectious diseases, and substance abuse.

Business area

Unlicensed pharmaceuticals

We are proud to be one of Sweden’s largest suppliers of unlicensed pharmaceuticals, i.e. pharmaceuticals that are not licensed in Sweden but are approved in other countries. Unlicensed pharmaceuticals are important alternatives when the prescribing doctor, dentist or veterinarian lacks a licensed drug required to treat a patient or animal. Unlicensed drugs may also be relevant if a licensed pharmaceutical is out of stock.

Unimedic Pharma is one of Sweden’s largest suppliers of unlicensed pharmaceuticals. An established network of suppliers in Europe and worldwide enable Unimedic Pharma to rapidly purchase and distribute unlicensed pharmaceuticals Unlicensed pharmaceuticals are important alternatives when the prescribing doctor, dentist or veterinarian lacks a licensed drug required to treat a patient or animal. Unlicensed drugs may also be relevant if a licensed pharmaceutical is out of stock.

The licence for an individual or patient group is granted by the Swedish Medical Products Agency based on a written statement from the prescriber. The pharmacy then applies for a temporary authorisation to dispense the drug. Unimedic Pharma has a well-established network of suppliers in Europe and worldwide which facilitates rapid acquisition and delivery of unlicensed pharmaceuticals. Unimedic Pharma handle all the documentation required for the acquisition of unlicensed pharmaceuticals. We continuously search the markets for new pharmaceuticals to further fulfil unmet medical needs, efforts which strengthens our ambition to contribute to better health.

The licence for an individual or patient group is granted by the Swedish Medical Products Agency based on a written statement from the prescriber. The pharmacy then applies for a temporary authorisation to dispense the drug. Unimedic Pharma has a well-established network of suppliers in Europe and worldwide which facilitates rapid acquisition and delivery of unlicensed pharmaceuticals. Unimedic Pharma handle all the documentation required for the acquisition of unlicensed pharmaceuticals. We continuously search the markets for new pharmaceuticals to further fulfil unmet medical needs, efforts which strengthens our ambition to contribute to better health.

Business area

Contract development and manufacturing organisation (CDMO)

Unimedic AB, sister company to Unimedic Pharma AB, is a full-service contract development and manufacturing organisation (CDMO) for pharmaceutical companies. Unimedic specializes in liquid pharmaceuticals and have long experience from sterile and non-sterile production. The CDMO is located in Matfors, outside Sundsvall in Sweden. The contract and manufacturing organisation started in the mid-60’s as an extempore pharmacy of the time, privately owned and located in Matfors. In the 1970’s, pharmacies were all nationalised and the laboratory in Matfors became part of ACO. Unimedic AB was founded in 1992 by Nils Ivrell, Lennart Leyonberg and Kenth-Olov Norman when Pharmacia ceased production. Since 2006, Unimedic is a wholly owned subsidiary of MedCap AB (publ), listed on Nasdaq Stockholm Mid Cap.

Commercial contract manufacturing

Unimedic has long experience of commercial contract manufacturing of pharmaceuticals. Our standard range include a wide choice of different types of containers like spray bottles, small/large plastic or glass bottles, ampoules, vials, sponges and sachets. Unimedic production lines are fully equipped to meet serialisation requirements. Unimedic conducts microbiological and chemical analyses of raw materials, water and finished products (in accordance with Swedish pharmaceutical standards and European Pharmacopoeia (Ph Eur)). Unimedic’s labelling and packing capabilities range from hand-packing to fully automatic packing lines. Unimedic offers a unique flexibility to customize batch-sizes.

Drug development | Tech Transfers

We make every effort to navigate and overcome any challenges associated with drug development and do our best to speed up the process through early tests and prepare for fast commercial launch.

As a customer to Unimedic you will benefit from many years of experience of contract manufacturing and our in-depth knowledge in drug development. Our competence and know-how ranges from liquid formulations based on small molecules to large molecular biological pharmaceuticals, as well as sterile and non-sterile solutions.

We can also supply investigational medicinal products (IMP) for clinical trials, or controlled drugs. In addition to full-scale manufacturing, we offer small-scale production of samples and stability testing.

Tech Transfers is part of our daily work and we are fully aware of the risks involved. Careful planning and meticulous documentation combined with full understanding of critical quality attributes and attention to detail at every step of the process ensure we offer new and existing customers smooth knowledge transfer and optimal process reproducibility of new products.

Contact Us, Unimedic Pharma

Contact Us

Please complete the form and briefly describe your enquiry/request.